Idiopathic Pulmonary Fibrosis Susceptibility Identified Via Genomic Markers
Altered expression of 14 genes in adults was associated with idiopathic pulmonary fibrosis susceptibility.
News
LATEST NEWS
COPD Morbidity Linked to Omega Fatty Acid Intake
An adverse association was observed between omega-6 polyunsaturated fatty acid intake and morbidity from chronic obstructive pulmonary disease.
Deep Learning Models Can Help Interpret Chest Radiographs
Models were developed to detect pneumothorax, opacity, nodule or mass, fracture on frontal chest radiographs
Physician Depressive Symptoms Linked to Higher Risk for Medical Errors
Bidirectional association was seen between depressive symptoms and medical errors.
Aspirin May Reduce Cancer, All-Cause Mortality in Seniors
Using aspirin 3 or more times per week may reduce all-cause and certain cancer type mortality.
Expert Consensus Survey: Prostacyclin Pathway Agent Use in Pulmonary Arterial Hypertension
A new consensus survey of expert opinions was published regarding the use of oral prostacyclin pathway agents in patients with various forms of pulmonary arterial hypertension.
CPAP Therapy Can Be Indicated in Likely Obstructive Sleep Apnea Without a Sleep Study
For patients with suspected obstructive sleep apnea, a previous sleep study may not be required to indicate the need for continuous positive airway pressure treatment.
Digital Sepsis Monitoring May Improve Patient Outcomes
System-wide implementation presents opportunity to improve care for patients who may have sepsis.
UPCOMING MEETINGS
FEBRUARY 22-25
American Academy of Allergy, Asthma and Immunology (AAAAI) 2019 Annual Meeting
San Francisco, CA
February 27-28
5th International Conference on Respiratory and Pulmonary Medicine
Paris, France
April 10-13
ELCC 2019: European Lung Cancer Conference
Geneva, Switzerland
DRUG NEWS FROM MPR
New Cheek Swab Helps Rule Out Genetic Form of COPD
FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation
Mepolizumab Approved for Younger Patients With Severe Eosinophilic Asthma
Fixed-Dose, Triple-Combination Therapy Effective in COPD Trial
Nangibotide Gets Fast Track Status for Treatment of Septic Shock
Rovalpituzumab Tesirine Program Ends After Poor Results in Lung Cancer Trial
Entrectinib Receives FDA Approval for Non-Small Cell Lung Cancer
Molgramostim Misses Primary End Point in Alveolar Pulmonary Proteinosis Trial
CDC Announces Number of Expired Flu Vaccines Administered Last Season
Sildenafil for Oral Suspension Available to Treat Pulmonary Arterial Hypertension
Glass Fragment Prompts Recall of Immunosuppressive Agent
Inhaled Molgramostim Granted Fast Track Status for Autoimmune Pulmonary Alveolar Proteinosis
Aclidinium Bromide and Formoterol Fumarate Approved for COPD Maintenance Treatment
Recombinant Human Pentraxin-2 Gets Breakthrough Tx Designation for Idiopathic Pulmonary Fibrosis
First Generic Version of Treprostinil Available for PAH
Want to read more?
Please login or register first to view this content.